August 21, 2015 — A molecular imaging biomarker is able to detect fast-growing primary prostate cancer and distinguish ...
Non-invasive stereotactic body radiation therapy (SBRT) is effective and well-tolerated by patients with inoperable early-stage or node-negative non-small cell lung cancer (NSCLC) tumors larger than 5 cm, according to a study published in the International Journal of Radiation Oncology Biology Physics.
A national risk model that gauges a woman’s chance of developing breast cancer has been refined to give a more accurate assessment. The revised figures, based on data from more than 1 million patients, reveal a 300 percent increase in a subset of women whose five-year risk is estimated at 3 percent or higher.
eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such ...
The biggest trends at the recent Association for Medical Imaging Management (AHRA) annual meeting included concerns over ...
ScanMed LLC CEO Randall Jones, Ph.D., MBA, introduced the prostate/pelvic magnetic resonance imaging (MRI) coil dedicated to prostate cancer detection on Omaha's CBS Action News 3 segment "The Morning Blend."

SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
Guided Therapeutics Inc. announced that it has presented the U.S. Food and Drug Administration (FDA) with a plan for advancing the pre-market approval (PMA) application for the LuViva Advanced Cervical Scan. In its “pre-submission” letter, the company also requested a meeting with the agency to finalize the plan.
While most women understand the importance of health screenings, an estimated 72 million have missed or postponed a ...
The ITM Group announced that its subsidiary ITG GmbH has successfully in-licensed DOTA-Zoledronate, a next-generation theranostic agent for bone targeted radionuclide therapy and diagnostics in patients suffering from bone metastases. DOTA-Zoledronate specifically targets cancerous bone lesions and, when radiolabeled with therapeutic or diagnostic radioisotopes, has shown high potential for positron emission tomography (PET) imaging and endoradiotherapy.
August 20, 2015 — Navidea Biopharmaceuticals announced publication of the results from an investigator-initiated ...
Learn more about myQA, IBA’s unique platform that connects QA applications, people, and know-how through a central ...
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
This brief video highlights the grassroots effort from IBA Dosimetry to satisfy customers through value added services ...
Laurel Bridge Software announced their Compass DICOM image routing solution is being implemented across the entire Veteran’s Health Administration (VHA) VistA Imaging system.
Cost of radiation therapy among Medicare patients varied most widely because of factors unrelated to a patient or that person’s cancer, reported University of California, San Diego School of Medicine researchers.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
Carestream Health announced its newest DRX digital imaging system, the Carestream DRX-Evolution Plus, is now available for order in many countries across the globe.
August 19, 2015 — A recent study by Mayo Clinic determined that adding molecular breast imaging (MBI) for women with ...
Grey Bruce Health Services’ regional hospital in Owen Sound, Canada, has adopted Carestream’s Vue PACS (picture archiving and communication system) and Vue Mammo workstations as part of its breast imaging program. The total solution includes Carestream’s digital breast tomosynthesis (DBT) module, full-field digital mammography (FFDM), breast ultrasound, breast magnetic resonance imaging (MRI), stereotactic biopsies and screening mammograms.
Varian Medical Systems Inc. announced it has, through one of its European subsidiaries, agreed to acquire Claymount, a privately-held, Netherlands-based supplier of components and subsystems for X-ray imaging equipment manufacturers. Varian's subsidiary in the Netherlands will pay approximately €50 million in cash for Claymount. The transaction was expected to close early in August.
The Radiology Leadership Institute (RLI) is launching the Leadership Accelerator Series. This new series uses the latest techniques and proven methodologies from leading institutions to offer attendees a total educational experience, complete with networking, peer learning and self-paced study — all without leaving home. Those who complete the series will earn the RLI Level II Leadership Proficiency Certificate.
Accuray Inc. announced that its CyberKnife and TomoTherapy systems have received the highest composite overall user satisfaction rating among radiation treatment delivery systems in the United States, according to the Q2 2015 MD Buyline Market Intelligence Briefing. The most recent ratings trend also shows Accuray has achieved the highest ratings among industry peers over the past two years.
GE Healthcare has become the first company with a low dose computed tomography (CT) lung cancer screening option that is cleared by the U.S. Food and Drug Administration (FDA) for lung cancer screening.
ViewRay Inc. announced in late July its successful completion of a reverse merger with ViewRay Technologies Inc. The combined entity will focus solely on the business of ViewRay, the makers of MRIdian, the world's first and only commercial magnetic resonance image (MRI)-guided radiation therapy system that images and treats cancer patients simultaneously. ViewRay will trade on the OTC Markets under the symbol "VRAY."